December 06, 2024

Why the first 10 minutes matter in precision oncology

"The world-renowned surgical oncologist, researcher and entrepreneur Prof. Dr. Hartmut Juhl relies on high-quality tissue samples and a data-based pipeline to advance precision medicine in cancer therapy." This article reflects on the Indivumed approach that the first 10 minutes matter to capture the molecular reality of cancer to find therapeutically novel targets, that change the field of precision oncology.

Read the full article in BIO Deutschlands yearbook 2024/2025.